Morphology of the subgenual prefrontal cortex in pediatric bipolar disorder

Hasan A Baloch1, John P Hatch, Rene L Olvera

  • 1CERT-BD, Department of Psychiatry, The University of North Carolina at Chapel Hill, 10614 Neurosciences Hospital, Campus Box 7160, Chapel Hill, NC 27599-7160, USA. Baloch@med.unc.edu

Insights

Pediatric bipolar disorder (PBD) patients with a family history of mood disorders may have smaller left subgenual prefrontal cortex (SGPFC) volumes. Mood stabilizers may influence SGPFC size in PBD.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Neuroimaging

Background:

  • The subgenual prefrontal cortex (SGPFC) is crucial for emotional regulation and reward processing.
  • Volumetric abnormalities in the SGPFC are noted in adult bipolar disorder but not well-studied in pediatric cases.
  • Pediatric bipolar disorder (PBD) requires further investigation into SGPFC structural differences.

Purpose of the Study:

  • To investigate SGPFC gray matter volumes in children and adolescents with PBD compared to healthy controls.
  • To explore the influence of family history of affective disorders and medication status on SGPFC volumes in PBD.

Main Methods:

  • Structural MRI scans (1.5 T) were acquired for 51 PBD subjects and 41 healthy controls (HC).
  • Manual tracing was used to determine SGPFC gray matter volumes.
  • Analysis of covariance (ANCOVA) controlled for age, gender, and intracranial volume.

Main Results:

  • No significant overall difference in SGPFC volume was found between PBD and HC subjects.
  • PBD subjects with a positive family history of mood disorders showed significantly smaller left SGPFC volumes than HC (p=0.03).
  • Mood stabilizer use in PBD was associated with larger right SGPFC volume (p=0.03).

Conclusions:

  • A smaller left SGPFC volume may be present in pediatric bipolar disorder patients with a strong family history of mood disorders.
  • Mood-stabilizing medication might affect SGPFC volume, potentially masking underlying differences.
  • These findings highlight the need to consider genetic vulnerability and medication effects in PBD neuroimaging studies.
Abstract

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Functional Brain Systems: Limbic System01:15

Functional Brain Systems: Limbic System

The limbic system, often called the "emotional brain," is a complex set of structures located deep within the brain. The intricate network of the limbic system supports a wide range of psychological functions, from emotional regulation to memory formation and sensory processing. This functional brain region encompasses specific parts of the diencephalon and the cerebrum, integrating the higher mental functions of the cerebral cortex with the primitive emotional responses of the deep brain...